FRANCE

Dunkerque

Our Dunkerque site offers world class large-scale manufacturing capabilities for custom synthesis and small-molecules APIs.

Minakem acquired AstraZeneca’s former API plant in Dunkirk and since 2009, the favourable proximity to Beuvry-la-Forêt R&D centre has allowed successful new production of commercial APIs or intermediate volumes for multi-step synthesis.

Our team can also offer regulatory filling support for the US, EU, Japan and China. 

Key Facts

  • Two separated production facilities with redundant utilities
  • Dedicated steroid workshop
  • 121 m3 reaction capacity
  • State-of-the-art, fully automated API facilities
  • High flexibility for capacity extension 

Compliance approvals

FDA / ANSM (EU/France) / Japan

Facility Details

Production capacities:

  • 42 reactors from 1200 to 8000 litres glass-lined, stainless steel or Hastelloy®
  • Hastelloy® centrifuge
  • 32 filter dryers from 0.8 to 6 m² stainless steel and Hastelloy® in ISO 8 isolation suites
  • Delumping and micronisation jet milling
  • Recycling of solvents

QC Lab

Core capabilities

  • cGMP custom synthesis and multi-tons scale
  • Process transfer, industrialization for commercial scale
  • Continuous process improvement
  • Chlorination
  • Stereoselective synthesis
  • Injectable APIs
  • Lithiation
  • Organometallic reactions
  • Cyanidation
  • Solvent recovery

Phone Number

Address

224, avenue de la Dordogne
59640 Dunkerque
France

Dunkerque – France

Commercial production of small molecule APIs

  • Large scale manufacturing
Montreal – Canada

Development and commercial production of small molecule APIs and Steroids

  • Fit for purpose process and analytical development with timely and robust scale-up from clinical to commercial supply
  • Dedicated steroid manufacturing unit
Louvain-la-Neuve – Belgium

Development and commercial production of small molecule Highly Potent APIs (HPAPIs) and Steroids

  • Fit for purpose process and analytical development with timely and robust scale-up from clinical to commercial supply
  • OEL: 0.1µg/m3/shift and Industrial Preparative HPLC
Beuvry-la-Foret – France

Development and commercial production of small molecule APIs

  • Fit for purpose process and analytical development with timely and robust scale-up from clinical to commercial supply
  • Home to Minakem’s R&D Center of Excellence